Clinical trial
Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag®…
NCT00255619 · Ministry of Health, Malaysia, Other · Completed
Key facts
| NCT number | NCT00255619 |
|---|---|
| Title | Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD. |
| Official title | A Randomized, Multi-Center, Open Label Trial to Establish the Equivalence Between ANDY-Disc® (Fresenius Medical Care) and Ultrabag® (Baxter) in Patients on CAPD. [CAPD-2 Trial] |
| Lead sponsor | Ministry of Health, Malaysia, Other |
| Collaborators | Fresenius Medical Care North America Industry Baxter Healthcare Corporation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Renal Failure |
| Intervention type | Device |
| Interventions | Baxter's UltraBag® and FMC Andy·Disc® |
| Enrollment | 264 |
| Start date | May 1, 2002 |
| Completion | May 1, 2004 |
| First posted | Nov 21, 2005 |
| Last update posted | Oct 26, 2006 |
| Countries | Malaysia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: